Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Leukemia Targeting Via Cytotoxic T Cells Expressing a CD33 Specific Chimeric Receptor.

Aurelie Dutour, PhD, Dean Lee, MD, PhD, Stephanie Napier, Helen Finney, PhD, Martin Pule, MD, William Choi, Malcolm Brenner, MB, PHD, Raphael Rousseau, MD, PHD

Blood (2006) 108 (11): 453.

https://doi.org/10.1182/blood.V108.11.453.453

Published: 2006

Journal Articles

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

J. Vera, MD, C. Quintarelli, PhD, B. Savoldo, MD, G. Giordano, PhD, A. Foster, PhD, M. Pule, MD, Helen Heslop, MD, C. Rooney, PhD, Malcolm Brenner, MD, PhD, G. Dotti, MD

Blood (2006) 108 (11): 1721.

https://doi.org/10.1182/blood.V108.11.1721.1721

Published: 2006

Journal Articles

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Joseph C. Fratantoni, MD, Linhong Li, PhD, Linda N. Liu, PhD, Madhusudan V. Peshwa, PhD, Malcolm Brenner, MD, PhD, Eric Yvon, MS, George Carrum, MD, Ettore Biagi, MD

Blood (2005) 106 (11): 450.

https://doi.org/10.1182/blood.V106.11.450.450

Published: 2005

Journal Articles

Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor–reactive cytotoxic T lymphocytes

Ettore Biagi, Gianpietro Dotti, Eric Yvon, Edward Lee, Martin Pule, Stephane Vigouroux, Stephen Gottschalk, Uday Popat, Raphael Rousseau, Malcolm Brenner

Blood (2005) 105 (6): 2436–2442.

https://doi.org/10.1182/blood-2004-07-2556

Published: 2005

Journal Articles

High Incidence but Low Morbitiy of Early Cytomegalovirus (CMV) Infections Following Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation with Alemtuzumab and Ganciclovir Prophylaxis.

Renu Lamba, MD, George Carrum, MD, Robert Krance, MD, Helen Heslop, MD, Malcolm Brenner, MD, Uday Popat

Blood (2004) 104 (11): 5098.

https://doi.org/10.1182/blood.V104.11.5098.5098

Published: 2004

Journal Articles

Immunotherapy of Chronic Lymphocytic Leukemia using CD40L and IL2 Expressing Autologous Tumor Cells.

Ettore Biagi, MD, Uday Popat, MD, Rousseau Raphael, MD, Yvon Eric, MS, Dotti Giampietro, MD, Rice Lawrence, MD, Michael Andreef, MD, PhD, Malcolm Brenner, MD, PhD

Blood (2004) 104 (11): 768.

https://doi.org/10.1182/blood.V104.11.768.768

Published: 2004

Journal Articles

Molecular Transfer of Human CD40 and OX40 Ligands to Leukemic Human B-CLL Cells Extensively Expands Tumor-Reactive Cytotoxic T-Lymphocytes.

Ettore Biagi, MD, Giampietro Dotti, MD, Eric Yvon, MS, Raphael Rousseau, MD, Edward Lee, MD, Stephen Gotschalk, MD, PhD, Malcolm Brenner, MD, PhD

Blood (2004) 104 (11): 951.

https://doi.org/10.1182/blood.V104.11.951.951

Published: 2004

Journal Articles

Targeted delivery of adenoviral vectors by cytotoxic T cells

Patricia Yotnda, Barbara Savoldo, Nicolas Charlet-Berguerand, Cliona Rooney, Malcolm Brenner

Blood (2004) 104 (8): 2272–2280.

https://doi.org/10.1182/blood-2003-11-3803

Published: 2004

Journal Articles

Gene Transfer by Adenovectors

Malcolm Brenner

Blood (1999) 94 (12): 3965–3967.

https://doi.org/10.1182/blood.V94.12.3965

Published: 1999

Journal Articles

IL-2 Adenovector-Transduced Autologous Tumor Cells Induce Antitumor Immune Responses in Patients With Neuroblastoma

Laura Bowman, Michael Grossmann, Donna Rill, Michael Brown, Wan-yun Zhong, Barbara Alexander, Thasia Leimig, Elaine Coustan-Smith, Dario Campana, Jesse Jenkins, Diane Woods, Geoffrey Kitchingman, Elio Vanin, Malcolm Brenner

Blood (1998) 92 (6): 1941–1949.

https://doi.org/10.1182/blood.V92.6.1941

Published: 1998

Journal Articles

CD40 Ligand Induces an Antileukemia Immune Response In Vivo

Dagmar Dilloo, Michael Brown, Marie Roskrow, Wanyung Zhong, Martha Holladay, William Holden, Malcolm Brenner

Blood (1997) 90 (5): 1927–1933.

https://doi.org/10.1182/blood.V90.5.1927

Published: 1997

Journal Articles

A Novel Herpes Vector for the High-Efficiency Transduction of Normal and Malignant Human Hematopoietic Cells

Dagmar Dilloo, Donna Rill, Claire Entwistle, Michael Boursnell, Wanyun Zhong, William Holden, Martha Holladay, Stephen Inglis, Malcolm Brenner

Blood (1997) 89 (1): 119–127.

https://doi.org/10.1182/blood.V89.1.119

Published: 1997

NARROW

Leukemia Targeting Via Cytotoxic T Cells Expressing a CD33 Specific Chimeric Receptor.

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor–reactive cytotoxic T lymphocytes

High Incidence but Low Morbitiy of Early Cytomegalovirus (CMV) Infections Following Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation with Alemtuzumab and Ganciclovir Prophylaxis.

Immunotherapy of Chronic Lymphocytic Leukemia using CD40L and IL2 Expressing Autologous Tumor Cells.

Molecular Transfer of Human CD40 and OX40 Ligands to Leukemic Human B-CLL Cells Extensively Expands Tumor-Reactive Cytotoxic T-Lymphocytes.

Targeted delivery of adenoviral vectors by cytotoxic T cells

Gene Transfer by Adenovectors

IL-2 Adenovector-Transduced Autologous Tumor Cells Induce Antitumor Immune Responses in Patients With Neuroblastoma

CD40 Ligand Induces an Antileukemia Immune Response In Vivo

A Novel Herpes Vector for the High-Efficiency Transduction of Normal and Malignant Human Hematopoietic Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only